Page 18 - 2019 Annual Report
P. 18
#2
AMERICAN INDIAN PHYSICIAN GRADUATES
fig. 1
fig. 3
fig. 2
fig. 4
#3
TRAINING & RURAL MEDICINE
Stronger Together
Hematologists/oncologists Erica Warlick, MD (fig. 1), and Jeffrey Miller, MD (fig. 2), see patients with acute myelogenous leukemia in their clinical practice. Now, they are leading a clinical trial for a new immunotherapy that takes advantage of a person’s own natural killer cells—tri-specific natural killer engagers or TriKETM.
TriKE technology stands on the shoulders of giants in immunology at the University of Minnesota.
In the 1960s, a young Max D. Cooper, MD (fig. 3), was laboring here in the laboratory of one of the founders of modern immunology, Robert
August
Medical School researchers receive $8.5 million grant to lead international study on enzyme mutation in stage 4 breast cancer tumors.
16
